FY2025 EPS Estimates for FULC Decreased by Cantor Fitzgerald
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) – Stock analysts at Cantor Fitzgerald decreased their FY2025 earnings estimates for Fulcrum Therapeutics in a research report issued to clients and investors on Thursday, October 30th. Cantor Fitzgerald analyst K. Kluska now anticipates that the company will post earnings per share of ($1.19) for the year, down […]
5 Nov 07:40 · The Markets Daily